170 related articles for article (PubMed ID: 37546627)
1. miR-34a-FOXP1 Loop in Ovarian Cancer.
Dirimtekin E; Mortoglou M; Alavanda C; Benomar Yemlahi A; Arslan Ates E; Guney I; Uysal-Onganer P
ACS Omega; 2023 Aug; 8(30):27743-27750. PubMed ID: 37546627
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of miR-34a and its target proteins of FOXP1, p53, and BCL2 in gastric MALT lymphoma and DLBCL.
He M; Gao L; Zhang S; Tao L; Wang J; Yang J; Zhu M
Gastric Cancer; 2014; 17(3):431-41. PubMed ID: 24232982
[TBL] [Abstract][Full Text] [Related]
3. MiR-374b-5p-FOXP1 feedback loop regulates cell migration, epithelial-mesenchymal transition and chemosensitivity in ovarian cancer.
Li H; Liang J; Qin F; Zhai Y
Biochem Biophys Res Commun; 2018 Oct; 505(2):554-560. PubMed ID: 30274777
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-152 inhibits ovarian cancer cell proliferation and migration and may infer improved outcomes in ovarian cancer through targeting FOXP1.
Qin W; Xie W; He Q; Sun T; Meng C; Yang K; Luo Y; Yang D
Exp Ther Med; 2018 Feb; 15(2):1672-1679. PubMed ID: 29434752
[TBL] [Abstract][Full Text] [Related]
5. LncRNA XIST promotes carboplatin resistance of ovarian cancer through activating autophagy via targeting miR-506-3p/FOXP1 axis.
Xia X; Li Z; Li Y; Ye F; Zhou X
J Gynecol Oncol; 2022 Nov; 33(6):e81. PubMed ID: 36335987
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-34a perturbs B lymphocyte development by repressing the forkhead box transcription factor Foxp1.
Rao DS; O'Connell RM; Chaudhuri AA; Garcia-Flores Y; Geiger TL; Baltimore D
Immunity; 2010 Jul; 33(1):48-59. PubMed ID: 20598588
[TBL] [Abstract][Full Text] [Related]
7. microRNA-605 inhibits the oncogenicity of non-small-cell lung cancer by directly targeting Forkhead Box P1.
Zhou W; Li R
Onco Targets Ther; 2019; 12():3765-3777. PubMed ID: 31190877
[No Abstract] [Full Text] [Related]
8. LncRNA OIP5-AS1 upregulates snail expression by sponging miR-34a to promote ovarian carcinoma cell invasion and migration.
Jiang X; Ye Z; Jiang Y; Yu W; Fang Q
Biol Res; 2020 Oct; 53(1):49. PubMed ID: 33092644
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of MicroRNA-34a Sensitizes Ovarian Cancer Cells to Resveratrol by Targeting Bcl-2.
Yao S; Gao M; Wang Z; Wang W; Zhan L; Wei B
Yonsei Med J; 2021 Aug; 62(8):691-701. PubMed ID: 34296546
[TBL] [Abstract][Full Text] [Related]
10. MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells.
Dong P; Xiong Y; Watari H; Hanley SJ; Konno Y; Ihira K; Yamada T; Kudo M; Yue J; Sakuragi N
J Exp Clin Cancer Res; 2016 Sep; 35(1):132. PubMed ID: 27596137
[TBL] [Abstract][Full Text] [Related]
11. FOXP1 functions as an oncogene in promoting cancer stem cell-like characteristics in ovarian cancer cells.
Choi EJ; Seo EJ; Kim DK; Lee SI; Kwon YW; Jang IH; Kim KH; Suh DS; Kim JH
Oncotarget; 2016 Jan; 7(3):3506-19. PubMed ID: 26654944
[TBL] [Abstract][Full Text] [Related]
12. NEAT1 regulates cell proliferation and apoptosis of ovarian cancer by miR-34a-5p/BCL2.
Ding N; Wu H; Tao T; Peng E
Onco Targets Ther; 2017; 10():4905-4915. PubMed ID: 29062236
[TBL] [Abstract][Full Text] [Related]
13. Serum exosomal microRNA-34a as a potential biomarker in epithelial ovarian cancer.
Maeda K; Sasaki H; Ueda S; Miyamoto S; Terada S; Konishi H; Kogata Y; Ashihara K; Fujiwara S; Tanaka Y; Tanaka T; Hayashi M; Ito Y; Kondo Y; Ochiya T; Ohmichi M
J Ovarian Res; 2020 Apr; 13(1):47. PubMed ID: 32336272
[TBL] [Abstract][Full Text] [Related]
14. MiR-34a suppresses ovarian cancer proliferation and motility by targeting AXL.
Li R; Shi X; Ling F; Wang C; Liu J; Wang W; Li M
Tumour Biol; 2015 Sep; 36(9):7277-83. PubMed ID: 25895459
[TBL] [Abstract][Full Text] [Related]
15. mRNA expression profile analysis reveals a C-MYC/miR-34a pathway involved in the apoptosis of diffuse large B-cell lymphoma cells induced by Yiqichutan treatment.
Zhai L; Zhao Y; Liu Z; Wu J; Lin L
Exp Ther Med; 2020 Sep; 20(3):2157-2165. PubMed ID: 32765691
[TBL] [Abstract][Full Text] [Related]
16. miR-29c-3p inhibits autophagy and cisplatin resistance in ovarian cancer by regulating FOXP1/ATG14 pathway.
Hu Z; Cai M; Zhang Y; Tao L; Guo R
Cell Cycle; 2020 Jan; 19(2):193-206. PubMed ID: 31885310
[TBL] [Abstract][Full Text] [Related]
17. MiR-34a-5p directly targeting TRIM44 affects the biological behavior of ovarian cancer cells.
Li HL; Duan YA; Zhao N
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1250-1260. PubMed ID: 33629295
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA miR-34a downregulates FOXP1 during DNA damage response to limit BCR signalling in chronic lymphocytic leukaemia B cells.
Cerna K; Oppelt J; Chochola V; Musilova K; Seda V; Pavlasova G; Radova L; Arigoni M; Calogero RA; Benes V; Trbusek M; Brychtova Y; Doubek M; Mayer J; Pospisilova S; Mraz M
Leukemia; 2019 Feb; 33(2):403-414. PubMed ID: 30111844
[TBL] [Abstract][Full Text] [Related]
19. Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling.
Yang MH; Lin BR; Chang CH; Chen ST; Lin SK; Kuo MY; Jeng YM; Kuo ML; Chang CC
Oncogene; 2012 May; 31(19):2401-11. PubMed ID: 21927029
[TBL] [Abstract][Full Text] [Related]
20. miRNA-34a decreases ovarian cancer cell proliferation and chemoresistance by targeting HDAC1.
Lv T; Song K; Zhang L; Li W; Chen Y; Diao Y; Yao Q; Liu P
Biochem Cell Biol; 2018 Oct; 96(5):663-671. PubMed ID: 29561664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]